Biopsy, Different Sites
In certain clinical scenarios, obtaining biopsies from multiple sites is practically and logistically feasible and clinically indicated. In pediatric populations, uncooperative and in patients with cognitive impairment, the biopsy procedures are best performed in an operating room under general anesthesia. If such patients require additional invasive procedures, they can be performed in the same sitting. This is common in the clinical management of pediatric malignancies such as neuroblastoma, rhabdomyosarcoma, melanoma; carcinoma of breast and lung; lymphomas, and systemic diseases such as sarcoidosis and amyloidosis, etc. Elderly people, patients with a strong family of cancers and individuals with germline mutations in protooncogenes and tumor suppressor genes are at a higher risk of developing neoplasms in different sites. Surveillance and screening programs in these individuals should include obtaining biopsies from different sites periodically. Preparing patients for different biopsies often involves a multidisciplinary teams and careful planning of the procedures. Some procedures may even require intraoperative assessment for adequacy. Risks and complications of such procedures vary from case to case.
- Staging malignant neoplasms; carcinoma, melanoma, lymphoma and pediatric neoplasms
- Surveillance of premalignant conditions such as Barret esophagus, colonic polyps, prostatic hyperplasia, cervical intraepithelial neoplasms, etc.
- Management of systemic inflammatory conditions such as sarcoidosis and amyloidosis
- Diagnosis of infectious processes
There are no universal reference ranges and the findings depend on the site biopsy taken.
Biopsy specimens are placed directly in formalin fixative. Cytology samples need to be placed in fixative solutions provided by the laboratory and vary depending on the commercial platforms used by the laboratory. Specimens requiring flow cytometry should be sent fresh to the laboratory in a sterile container or RPMI medium. Rarely, if culture is indicated, tissue for culture should be sent in a sterile container (or appropriate transport media) to the laboratory for microbiological assessment.
- J Urol. 1997 Jan;157(1):33-7. [PMID: 8976209]
- Eur Urol. 2013 Feb;63(2):321-32. [PMID: 23088996]
- Pathologica. 2001 Dec;93(6):688-92. [PMID: 11785124]
- J Clin Pathol 2001;54:657–663 [PMID: 11533068]
- Semin Dial. 2003 Jul-Aug;16(4):341-5 [PMID: 12926408]
- Am J Clin Pathol. 2017 May 1;147(5):473-476 [PMID: 28371845]
- Ann Clin Lab Sci. 2017 Nov;47(6):663-667 [PMID: 29263039]
- Dig Dis Sci. 2015 Mar;60(3):639-46 [PMID: 25511920]
- Dig Liver Dis. 2013 Oct;45(10):816-9 [PMID: 23707404]
- J Minim Invasive Gynecol. 2012 Jul-Aug;19(4):490-3 [PMID: 22417904]
- J Obstet Gynaecol Can. 2018 Jun 21 Epub ahead of print [PMID: 29937135]
- Br J Dermatol. 1987; 117(4): 471-8. [PMID: 3314971]
- FJ Am Board Fam Pract. 1996; 9(6): 397-404. [PMID: 8923396]
- Rheumatology (Oxford). 2010 Nov;49(11):2117-21. [PMID: 20660500]
- Acta Cytol. 2014;58(6):552-62. [PMID: 25171320]
- PLoS One. 2018 Jan 22;13(1):e0191590. [PMID: 29357388]
- Future Oncol. 2015;11(2 Suppl):43-6. [PMID: 25662328]
- Eur Radiol. 2015 Nov;25(11):3354-60 [PMID: 25903714]
- Diagn Interv Imaging. 2016 Oct;97(10):965-972 [PMID: 27481575]